Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
21 - 30 out of 69Page size: 10
Sort by: Title
  1. Published

    Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease

    McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Greene, T., Held, C., Hou, F., Mann, J. F. E., Rossing, Peter, Sjöström, C. D., Toto, R. D., Langkilde, A. M., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Circulation. 143, 5, p. 438-448

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Ripa, Rasmus Sejersten, Zobel, E. H., von Scholten, B. J., Jensen, Jacob Kildevang, Binderup, Tina, Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Circulation: Cardiovascular Imaging. 14, 7, 13 p., 012174.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Heerspink, H. J. L., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Greene, T. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 743-754 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Jongs, N., Greene, T., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 755-766 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Hansen, T. W., Rossing, Peter & Størling, Joachim, 2021, In: Scientific Reports. 11, 18522.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of liraglutide on vascular inflammation evaluated by [64 cu]dotatate

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Curovic, V. R., Diaz, L. J., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Diagnostics. 11, 8, 11 p., 1431.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

    McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Hou, F. F., Rossing, Peter, Sjöström, C. D., Solomon, S. D., Toto, R. D., Langkilde, A. M., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: JACC: Heart Failure. 9, 11, p. 807-820 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effects of dapagliflozin in stage 4 chronic kidney disease

    Chertow, G. M., Vart, P., Jongs, N., Toto, R. D., Gorriz, J. L., Hou, F. F., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefánsson, B. V., Langkilde, A. M., Wheeler, D. C. & Heerspink, H. J. L., 2021, In: Journal of the American Society of Nephrology. 32, 9, p. 2352-2361 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 1, p. 22-31 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: European Heart Journal. 42, 13, p. 1216-1227 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 12937790